Cello Group PLC | Balance Sheet

Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
5,984.00
5,566.00
5,249.00
7,466.00
13,021.00
10,424
Total Accounts Receivable
29,257.00
31,197.00
36,651.00
44,912.00
52,276.00
45,538
Other Current Assets
7,063.00
8,847.00
7,032.00
1,950.00
2,244.00
2,320
Total Current Assets
42,304.00
45,610.00
48,932.00
54,328.00
67,541.00
58,282
Net Property, Plant & Equipment
2,212.00
2,321.00
1,950.00
2,705.00
2,840.00
2,931
Intangible Assets
72,467.00
74,888.00
74,723.00
70,528.00
74,146.00
75,011
Total Assets
117,775.00
123,717.00
126,484.00
128,303.00
145,608.00
137,737
ST Debt & Current Portion LT Debt
386.00
334.00
256.00
171.00
73.00
Accounts Payable
12,700.00
16,871.00
14,104.00
14,449.00
14,285.00
Income Tax Payable
1,271.00
1,241.00
1,823.00
851.00
438.00
Other Current Liabilities
25,703.00
22,419.00
28,497.00
33,722.00
35,093.00
Total Current Liabilities
40,060.00
40,865.00
44,680.00
49,193.00
49,889.00
Long-Term Debt
9,159.00
12,424.00
9,160.00
12,367.00
11,336.00
Provision for Risks & Charges
-
-
-
-
1,400.00
Deferred Taxes
500.00
649.00
746.00
679.00
971.00
Other Liabilities
-
700.00
1,693.00
126.00
-
Total Liabilities
49,511.00
54,238.00
55,666.00
61,749.00
62,735.00
Common Equity (Total)
68,218.00
69,434.00
70,768.00
66,554.00
82,873.00
Total Shareholders' Equity
68,218.00
69,434.00
70,768.00
66,554.00
82,873.00
Total Equity
68,264.00
69,479.00
70,818.00
66,554.00
82,873.00
Liabilities & Shareholders' Equity
117,775.00
123,717.00
126,484.00
128,303.00
145,608.00
Accumulated Minority Interest
46.00
45.00
50.00
-
-

About Cello Group

View Profile
Address
11-13 Charterhouse Buildings
London London & South East EC1M 7AP
United Kingdom
Employees -
Website http://cellogroup.co.uk
Updated 07/08/2019
Cello Health Plc is a global insight and strategic marketing group with a primary focus on the pharmaceutical and health sectors. It operates through two segments: Cello Health and Cello signal. The Cello Health segment provides market research, consulting, and communications services principally to its pharmaceutical and healthcare clients.